Pierre Layrolle obtained a Ph.D. in biomaterials from the University of Toulouse in 1994. He then spent 2 years in Tsukuba, Japan as a post-doctoral researcher. For 5 years, he worked as a Senior Research Scientist in the tissue engineering company IsoTis in The Netherlands. In 2003, he joined INSERM as Director of Research in Nantes leading a team on bone tissue engineering. He was the coordinator or partner of several European projects (REBORNE, MAXIBONE, ORTHOUNION, PARAGEN, ORTHO ALLO UNION) to translate innovative bone regenerative therapies into clinical trials. From 2010 to 2020, he started to study bone tumors and led a research team on inflammation and cell communications in bone pathologies. In 2021, he has  moved to Inserm, ToNIC lab in Toulouse to develop 3D bioprinting and organs on chips. Pierre Layrolle has authored around 250 peer-reviewed publications (22800 citations, h-index 80) and invented 15 patents.